A few weeks ago, a patient of mine experienced a cardiac event — his heart stopped. Completely.
Pacemakers
This channel includes news and new technology innovations for pacemakers used to treat bradycardia.
-
-
Robert Kowal, M.D., chief medical officer of the Medtronic cardiac rhythm and heart failure division, said there...
-
October 27, 2020 – Magnetic resonance imaging (MRI) examinations can be safely performed in...
-
Interview with Andrew D. Krahn, M.D., FHRS, head of the division of cardiology at St.
The new ACC Electrophysiology (EP) Device Implant Registry, part of the National Cardiovascular Data Registry (NCDR) will include data on implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) procedures previously captured in the NCDR ICD Registry, as well as provide the flexibility to capture novel pacemaker procedures. The registry is aligned with the ACC’s Electrophysiology Accreditation program, fully supporting the program’s data requirements.
News | EP Lab | April 02, 2021
April 2, 2021 — Today, the American College of Cardiology (ACC) launched the Electrophysiology (EP) Device Implant...
Integrating data from an array of implantable EP devices from different vendors can be difficult or require disconnected silos of data for different vendors. One solution that was recently introduced to integrate data from various vendors is the Optimize EP software, which allows viewing data from all device vendors in one platform to streamline workflows.
Feature | EP Lab | March 17, 2021 | By Maninder Bedi, M.D.
A few weeks ago, a patient of mine experienced a cardiac event — his heart stopped. Completely. However, his...
The Optimize EP CaRM software integrates data from several EP devices a patients may use and aggregate it into one location.
News | EP Lab | February 02, 2021
February 2, 2021 – Optimize EP, a digital health company focused on transforming cardiac care by improving the current...
Videos | EP Device Monitoring Systems | December 22, 2020
Robert Kowal, M.D., chief medical officer of the Medtronic cardiac rhythm and heart failure division, said there has...
Chest X-ray from a patient included in the study. Posteroanterior view, of a 79-year-old man with history of a previous pacemaker, with abandoned right atrial and right ventricular pacing leads on the right side at time of new cardiac resynchronization therapy defibrillator implant on the left side. Arrows indicate a nodular opacity in the right midlung concerning for mass. Find more images of patients in this study in Radiology: Cardiothoracic Imaging.
Feature | Magnetic Resonance Imaging (MRI) | October 27, 2020
October 27, 2020 – Magnetic resonance imaging (MRI) examinations can be safely performed in patients with non-MR...
News | Pacemakers | June 16, 2020
June 16, 2020 - Biotronik has today announced its commitment to giving physicians additional tools to pace in the His-...
Videos | HRS | May 22, 2020
Interview with Andrew D. Krahn, M.D., FHRS, head of the division of cardiology at St. Paul’s Hospital, and professor of...
Videos | Heart Valve Technology | February 18, 2020
Andrew Weintraub, M.D., FACC, associate director, of the Interventional Cardiology and Vascular Center, medical...
Videos | Pacemakers | February 13, 2020
This video illustrates how the Micra AV leadless pacemaker is delivered via catheter and enables atrioventricular (AV)...
News | Pacemakers | February 13, 2020
February 13, 2020 — The U.S. Food and Drug Administration (FDA) has approval of Micra AV, the world’s smallest...
News | Pacemakers | November 15, 2019
(February 2020 update — the results of this trial led to the FDA clearnace of the Micra AV device in January 2020 - FDA...
Co-principal investigator professor Aydin Babakhani at the UCLA Integrated Sensor Laboratory holds an earlier version of the prototype leadless, wireless and battery-less pacemaker. Photo Credit: Cody Duty, Texas Medical Center.
News | Pacemakers | November 13, 2019
November 13, 2019 — Texas Heart Institute (THI) was awarded a prestigious four-year, $2.39 million grant from the...
The BackBeat CNT system is a bioelectronic treatment that immediately, substantially and chronically lowers blood pressure (BP) while simultaneously modulating the autonomic nervous system (ANS).
News | Hypertension | October 10, 2019
October 10. 2019 — Late-breaking results from its MODERATO II double-blind, randomized study of BackBeat Cardiac...
Similar to a pacemaker, the Barostim Neo System uses a pulse generator implanted below the collar bone with a lead that attaches to the carotid artery in the neck. It delivers electrical impulses to baroreceptors in the neck, which sense how blood is flowing through the carotid arteries and relays information to the brain. The brain, in turn, sends signals to the heart and blood vessels that relax the blood vessels and inhibit the production of stress-related hormones to reduce heart failure symptoms.
Technology | Heart Failure | August 19, 2019
August 19, 2019 — The U.S. Food and Drug Administration (FDA) granted market clearance the Barostim Neo System for the...
News | EP Lab | July 31, 2019
July 31, 2019 — The chances of patients experiencing complications after having a cardiac device implanted vary...
